Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer

NCT02012634 · clinicaltrials.gov ↗
UNKNOWN
Status
340
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Xijing Hospital

Collaborators